Cargando…
PPARs: Protectors or Opponents of Myocardial Function?
Over 5 million people in the United States suffer from the complications of heart failure (HF), which is a rapidly expanding health complication. Disorders that contribute to HF include ischemic cardiac disease, cardiomyopathies, and hypertension. Peroxisome proliferator-activated receptors (PPARs)...
Autores principales: | Pol, Christine J., Lieu, Melissa, Drosatos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680114/ https://www.ncbi.nlm.nih.gov/pubmed/26713088 http://dx.doi.org/10.1155/2015/835985 |
Ejemplares similares
-
NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020) -
Publisher Correction: NK cells in COVID-19: protectors or opponents?
por: Alrubayyi, Aljawharah
Publicado: (2020) -
Professor Tyndall and His Opponents
por: Winn, J. M.
Publicado: (1876) -
PPARs and Myocardial Infarction
por: Wagner, Kay-Dietrich, et al.
Publicado: (2020) -
Protectors or Perpetrators
por: Mathew, BC, et al.
Publicado: (2009)